Clinical Trials Logo

Filter by:
NCT ID: NCT01511861 Active, not recruiting - Diabetes Mellitus Clinical Trials

Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device

Start date: November 2010
Phase:
Study type: Observational

Adequate glycemic control in patients with Diabetes Mellitus (DM) is a desired therapeutic goal that is difficult to achieve with current blood glucose monitoring technology. Home blood glucose monitoring (HBGM) technology, which requires finger pricking, is a source of severe inconvenience and hence, a lack of compliance.Thus, the need for non-invasive and easy to operate glucose monitoring in DM patients for strict glycemic control cannot be overemphasized. The Glucometer GM-205 blood glucose readings are accurate and measure blood glucose with an acceptable mean relative error when compared to acceptable invasive blood glucose measurements. The primary objectives of the trial are to determine: 1. Assessing the reliability of the Glucometer GM-205 in evaluating blood glucose levels compare to the standard glucose blood test 2. Creating database of glucose levels readings utilizing the Glucometer GM-205.

NCT ID: NCT01510808 Recruiting - Clinical trials for Aggressive Periodontitis

The Affect of Orthodontic Treatment on the Periodontal Status of Patients With Aggressive Periodontitis

Start date: January 2012
Phase: N/A
Study type: Observational

Orthodontic Treatment will affect the periodontal status of periodontally treated Aggressive Periodontitis patients.

NCT ID: NCT01510652 Completed - Heart Failure Clinical Trials

More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges

MORE-CRT
Start date: November 2011
Phase: N/A
Study type: Interventional

This investigation is designed with the hypothesis that using a quadripolar left ventricular lead results in less interventions when dealing with high pacing thresholds and Phrenic Nerve Stimulation (PNS), both at implant and during follow-up, compared to standard bipolar left ventricular leads.

NCT ID: NCT01510184 Terminated - Clinical trials for Diffuse Large B-cell Lymphoma

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Start date: April 19, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Zevalin compared with observation alone in participants who are in PET-negative complete remission after first-line R-CHOP or R-CHOP like therapy.

NCT ID: NCT01510015 Not yet recruiting - Cannabis Dependence Clinical Trials

Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel

Start date: January 2012
Phase: N/A
Study type: Interventional

This study evaluates the effects of psychological and pharmacological treatment of regular users of cannabis and psychostimulants in a treatment center (Kfar Izun) in Israel. The participants will undergo psychological evaluation before and during treatment and follow up at 4 months. Ten participants will undergo brain imaging of the dopamine receptor D2 in order to evaluate the effects of treatment on dopamine turnover in the brain. A control group of psychiatric in-patients undergoing treatment for psychiatric illness with be recruited from Geha Hospital in Israel. It is predicted that successful treatment of regular users of cannabis will be resulted in improvement in anxiety, depression and psychotic symptoms as well as in upregulation of dopamine turnover in participants that will undergo brain imaging.

NCT ID: NCT01509911 Active, not recruiting - Clinical trials for Metastatic Pancreatic Cancer

A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment

Start date: January 2012
Phase: Phase 2
Study type: Interventional

TL-118 is an anti-angiogenic drug combination designed for the treatment of cancer. The investigational product Tl-118 comprises of four well-known active components. The therapy is administrated at a unique dosing regimen that was found to be effective and advantageous in terms of safety. The product is formulated as an oral suspension, conveniently administrated by the patients at home and not requiring medical staff assistance. This Phase II clinical trial aims to evaluate the efficacy, safety and tolerability of TL-118 in Gemcitabine treated Pancreatic Cancer patients

NCT ID: NCT01509898 Recruiting - Peri-implantitis Clinical Trials

The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

Start date: July 18, 2012
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the effect of a dental water jet on initial peri-implant disease resolution.

NCT ID: NCT01509859 Recruiting - Clinical trials for Closed Comminuted Oblique Intertrochanteric Fracture of Neck of Right Femur

Comparing Weight Bearing After Intramedullary Fixation Devices for the Proximal Femur Fracture

Start date: December 2011
Phase: Phase 4
Study type: Interventional

The purpose of the study is to Compare the stability of the fracture and pain after surgery by measuring the stride length and weight bearing on the operated leg. This study will compare these parameters between two different proximal femur nails used for fixing hip fractures.

NCT ID: NCT01509170 Not yet recruiting - Hyponatremia Clinical Trials

The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia

0597-10-HMO
Start date: February 2012
Phase: N/A
Study type: Observational

The aim of this study is to identify factors associated with hyponatremia among patients hospitalized in the internal medicine ward. Consequtive patients hospitalized because of hyponatremia will be recruited. Follow up will include clinical factors such as background diseases, complete drug history, blood tests including Biochemistry tests (Sodium, renal function), endocrinological evaluation, thyroid function tests, cortisol,urinary sodium on addmition. One month following discharge follow up Sodium level will be taken.

NCT ID: NCT01509157 Completed - Type 1 Diabetes Clinical Trials

MDRS for Prevention of Nocturnal Hypoglycemia

MDRS
Start date: January 2012
Phase: Phase 1
Study type: Interventional

The investigators have developed a unique Remote & Safety diabetes management system (MDRS) that offers real-time remote monitoring and control of glucose levels. The system allows the supervising personal to alarm the patient and intervene in cases such as pending hypoglycemia, long standing hyperglycemia or technical faults.The aim of this feasibility study is to evaluate the efficacy of the MDRS system in preventing nocturnal hypoglycemia in children and young adults with type 1 diabetes.